The 2020 PATDD course will be held in the Moeller Centre, Cambridge 29th June – 3rd July
This highly acclaimed course will provide training in toxicology as applied in drug development to scientists from all parts of the World. Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with emphasis on the practical application of these principles and interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective. Through the week the students will participate in tutored group study of regulatory cases and original data from a regulatory submission which will conclude with a half-day workshop.
The course is intended to benefit individuals from biotechnology and pharmaceutical companies working with either small or large molecules, along with those from CROs, regulatory agencies and academia who are interested in toxicology and its application in safety assessment of drugs and medical products and for toxicologists early in their career seeking more in-depth knowledge and understanding of the role of toxicology in safety assessment. It is also suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) making a career change to work in drug safety assessment.
The course is recognised by EUROTOX as providing 37 hours of CPD and is approved by the Royal Society of Biology for 96 CPD credits.
Further Details – CLICK HERE